DaVita HealthCare Ownership
| DVA Stock | USD 140.75 0.41 0.29% |
Shares in Circulation | First Issued 1994-06-30 | Previous Quarter 85.8 M | Current Value 81.3 M | Avarage Shares Outstanding 185.7 M | Quarterly Volatility 52.8 M |
DaVita Stock Ownership Analysis
About 50.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.99. DaVita HealthCare recorded earning per share (EPS) of 10.08. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 9th of September 2013. DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. Davita Healthcare operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 69000 people. To learn more about DaVita HealthCare Partners call Javier Rodriguez at 720-631-2100 or check out https://www.davita.com.Besides selling stocks to institutional investors, DaVita HealthCare also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different DaVita HealthCare's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align DaVita HealthCare's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
DaVita HealthCare Quarterly Liabilities And Stockholders Equity |
|
DaVita HealthCare Insider Trades History
About 50.0% of DaVita HealthCare Partners are currently held by insiders. Unlike DaVita HealthCare's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against DaVita HealthCare's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of DaVita HealthCare's insider trades
DaVita Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as DaVita HealthCare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DaVita HealthCare Partners backward and forwards among themselves. DaVita HealthCare's institutional investor refers to the entity that pools money to purchase DaVita HealthCare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Amundi | 2025-03-31 | 517.7 K | Ubs Group Ag | 2025-03-31 | 484.7 K | Charles Schwab Investment Management Inc | 2025-03-31 | 468.7 K | Ubs Asset Mgmt Americas Inc | 2025-03-31 | 448.3 K | Holocene Advisors, Lp | 2025-03-31 | 409.6 K | Allianz Asset Management Ag | 2025-03-31 | 408.8 K | Td Global Investment Solutions – Td Epoch | 2025-03-31 | 407.9 K | Bank Of New York Mellon Corp | 2025-03-31 | 376.3 K | Squarepoint Ops Llc | 2025-03-31 | 369.9 K | Berkshire Hathaway Inc | 2025-03-31 | 35.1 M | Vanguard Group Inc | 2025-03-31 | 5.1 M |
DaVita HealthCare Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DaVita HealthCare insiders, such as employees or executives, is commonly permitted as long as it does not rely on DaVita HealthCare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DaVita HealthCare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
DaVita HealthCare's latest congressional trading
Congressional trading in companies like DaVita HealthCare, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in DaVita HealthCare by those in governmental positions are based on the same information available to the general public.
| 2024-01-16 | Senator Jerry Moran | Acquired Under $15K | Verify | ||
| 2024-01-11 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2023-07-13 | Senator Tommy Tuberville | Acquired Under $15K | Verify |
DaVita HealthCare Outstanding Bonds
DaVita HealthCare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. DaVita HealthCare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most DaVita bonds can be classified according to their maturity, which is the date when DaVita HealthCare Partners has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| DAVITA INC 375 Corp BondUS23918KAT51 | View | |
| DaVita 4625 percent Corp BondUS23918KAS78 | View |
DaVita HealthCare Corporate Filings
8K | 17th of July 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 13th of June 2025 Other Reports | ViewVerify | |
F4 | 27th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 25th of April 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether DaVita HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DaVita HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Davita Healthcare Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Davita Healthcare Partners Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Earnings Share 10.08 | Revenue Per Share | Quarterly Revenue Growth 0.05 | Return On Assets |
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.